Bruno Carmine, Tralongo Pietro, Vegni Federica, Feraco Angela, Zhang Qianqian, Padial-Urtueta Belen, Carlino Angela, Pontecorvi Alfredo, Fadda Guido, Raffaelli Marco, Larocca Luigi Maria, Pantanowitz Liron, Rossi Esther Diana
Division of Endocrinology Fondazione Policlinico Universitario"Agostino Gemelli"-IRCCS, Rome Italy.
Division of Anatomic Pathology and Histology Fondazione Policlinico Universitario"Agostino Gemelli"-IRCCS, Rome Italy.
Pathologica. 2025 Apr;117(2):111-120. doi: 10.32074/1591-951X-1091.
The American Thyroid Association (ATA) updated guidelines for the treatment of thyroid cancer, leading to a less aggressive approach depending on clinical-pathological features. As a result, the possibility to perform lobectomy versus total thyroidectomy has significantly increased. The majority of thyroid cancers are indolent with an excellent prognosis, while only 15% of patients with well-differentiated carcinoma, including papillary thyroid carcinoma (PTC), have locally advanced thyroid cancer (LATC) at diagnosis. We reviewed our practice in treating thyroid carcinoma over the last decade.
From January 2010 to December 2020, 1057 patients with uninodular benign and malignant thyroid lesions were reviewed.
Among these cases, 77% were women with a median age of 49.3 years. The series involved 307 malignant diagnoses (29.05%) including 196 (61.6%) classic PTC and 38 (12%) aggressive variants of PTC, mostly tall cell variant (30 cases, 9.4%). Among malignant cases, multifocality was microscopically documented in 84 cases (26.4%). Using the ATA distribution of risk, there were 239 cases in the low risk and 68 in the intermediate risk categories. Second surgery was assessed in a total of 150 cases, showing 42 cases with additional thyroid cancer foci in the other lobe (26 single vs 16 multiple foci). Ten cases had metastatic perithyroidal lymph nodes.
Our data could be the basis for performing a longitudinal study in order to establish which risk factors can predict bilateral involvement and to suggest a tailored surgical approach.
美国甲状腺协会(ATA)更新了甲状腺癌治疗指南,根据临床病理特征采取了不那么激进的治疗方法。因此,行甲状腺叶切除术与全甲状腺切除术的可能性显著增加。大多数甲状腺癌生长缓慢,预后良好,而在诊断时,只有15%的分化型甲状腺癌患者,包括乳头状甲状腺癌(PTC),患有局部晚期甲状腺癌(LATC)。我们回顾了过去十年中我们治疗甲状腺癌的实践。
回顾2010年1月至2020年12月期间1057例单发性甲状腺良恶性病变患者的情况。
在这些病例中,77%为女性,中位年龄为49.3岁。该系列包括307例恶性诊断(29.05%),其中196例(61.6%)为经典PTC,38例(12%)为PTC的侵袭性变体,主要是高细胞变体(30例,9.4%)。在恶性病例中,84例(26.4%)在显微镜下记录有多灶性。根据ATA风险分布,低风险类别有239例,中风险类别有68例。总共对150例患者进行了二次手术,其中42例在另一叶发现额外的甲状腺癌病灶(26例为单个病灶,16例为多个病灶)。10例患者有甲状腺周围淋巴结转移。
我们的数据可为开展纵向研究提供依据,以确定哪些风险因素可预测双侧受累情况,并建议采用个性化的手术方法。